Company intelligence / Profile preview

Aventior

Cambridge, Massachusetts, United Statesaventior.com ↗

Ownership: Private
Employees: ~171
Development stage: Other

Overview

Aventior provides advanced AI-driven digital solutions to pharmaceutical, biotech, cell/gene therapy, diagnostics companies. Their platforms streamline research data integration/analytics from R&D through post-market intelligence. They enable faster clinical trial execution and improved compliance with regulatory standards via automation of batch records and process verification. Their digital pathology tools leverage OCR/image processing to structure slide label data for efficient retrieval.

Modalities: Cell therapyGene therapyBiologicsSmall molecule
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Leading global pharmaceutical/biotech/cell & gene therapy companies (as clients)

Beyond the preview

Go deeper on Aventior.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aventior.

Explore the full profile